Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | Challenges in treating cancers of unknown primary (CUP)

Thomas Helleday • 29 Sep 2019
ESMO 2019
General

Thomas Helleday, MD, PhD, Karolinska Institute, Stockholm, Sweden & University of Sheffield, Sheffield, UK, highlights the issues with treating cancers of unknown primary (CUP), which result in a poor prognosis for patients. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

More from Thomas Helleday

Targeting the DNA damage response
2:40
Targeting the DNA damage response
Thomas Helleday • 29 Sep 2019
PARP inhibitors for ovarian cancer - room for improvement with HRD testing
1:25
PARP inhibitors for ovarian cancer - room for improvement with HRD testing
Thomas Helleday • 30 Sep 2019
Immunotherapy priming with neo-antigens
2:49
Immunotherapy priming with neo-antigens
Thomas Helleday • 1 Jun 2019
The DNA damaging revolution
3:07
The DNA damaging revolution
Thomas Helleday • 1 Jun 2019

Related Videos

Drug price competition and the potential for tendering in oncology care
1:34
Drug price competition and the potential for tendering in oncology care
Daniel Goldstein • 23 Oct 2026
What financial challenges patients and healthcare systems face in oncology?
1:11
What financial challenges patients and healthcare systems face in oncology?
Daniel Goldstein • 23 Oct 2026
How can we enhance the efficacy of TILs therapy in solid tumors?
2:27
How can we enhance the efficacy of TILs therapy in solid tumors?
Paolo Ascierto • 23 Oct 2026
Cellular therapy advances and regulatory approvals in oncology in 2026
1:57
Cellular therapy advances and regulatory approvals in oncology in 2026
Paolo Ascierto • 23 Oct 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals